Shire launches US$12.1bn four-part deal: Lead
(Adds launch levels)
By Mike Gambale and Hillary Flynn
NEW YORK, Sept 19 (IFR) - Here is the pricing progression on
the new bond offering from drugmaker Shire (Hamburg: 3979575.HM - news) (Baa3/BBB-) to help
finance its acquisition of Baxalta (Berlin: 9BX.BE - news) , one of the banks leading the
deal told IFR.
The deal is expected to price later on Monday.
SIZE MATURITY IPTs (T+) Guidance Launch (T+)
(T+)
US$3.3bn 3yr FXD 120-125bp 105bp 100bp
area*
US$3.3bn 5yr FXD 140-145bp 125bp 120bp
area
US$2.5bn 7yr FXD 160-165bp 140bp 135bp
area
US$3bn 10yr FXD 175-180bp 155bp 150bp
area
Active bookrunners: Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) ,
Morgan Stanley (Xetra: 885836 - news)
* Area is +/- 5bp area
(Reporting by Mike Gambale; Editing by Natalie Harrison, Marc
Carnegie and Paul Kilby)